PHI with breast cyst surgery
How does this condition affect your private health insurance?
Mammazystenoperation refers to the surgical removal of a benign, fluid-filled sac (cyst) from the breast tissue. This procedure is typically performed when a breast cyst is large, painful, rapidly growing, recurs frequently after aspiration, or if there's suspicion of malignancy after diagnostic imaging and biopsy. The surgery usually involves a small incision to excise the cyst, often under local or general anesthesia. Its primary goal is to alleviate symptoms, confirm benignity, and prevent recurrence in that specific location. Recovery is generally straightforward, with minimal downtime and a high success rate.
PKV Risk Assessment
Impact on Your Insurance Policy
Duration of Illness (Initial)
A few days for acute recovery post-surgery, up to several weeks for full wound healing and resolution of discomfort.
Duration of Illness (Lifetime)
Typically a one-time event for the specific treated cyst; however, new cysts may develop over a lifetime, potentially requiring further intervention.
Cost of Treatment (Initial)
Ranges from €2,000 to €8,000 depending on the healthcare system, facility, and type of anesthesia.
Cost of Treatment (Lifetime)
Generally similar to the cost of first occurrence if no further surgeries are required; cumulative if multiple cysts or recurrences necessitate additional procedures.
Mortality Rate
<0.01% (extremely rare, usually related to complications from anesthesia or underlying health issues rather than the procedure itself).
Risk of Secondary Damages
Low to moderate: Scarring (100%), temporary pain and swelling (common). Less common: Infection (~1-5%), hematoma/seroma (~5-10%), temporary or permanent numbness due to nerve irritation (~5-15%), minor cosmetic changes or indentation.
Probability of Full Recovery
Very high (>95%) for resolution of symptoms related to the specific cyst and return to normal activity, though scarring is permanent.
Underlying Disease Risk
Low probability of associated underlying malignancy (unless surgical removal was indicated due to suspicious findings). Often associated with benign fibrocystic changes in the breast tissue.